Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Juniper Community Council’s 9th annual Star Search to take place April 3; sign up today
- Register to play in this weekend’s badminton tournament
- Scholar to discuss Stevie Wonder’s exploration of technology at next Baker-Nord Center event
- Political scientist to explain how democracy assistance doesn’t confront dictators
- Organizational Development and Learning Unit to host series on conflict management, workplace violence